2421. Tedizolid Is Well-Tolerated Among Patients Receiving Prolonged Treatment Courses

BACKGROUND: Tedizolid (TED) is a newly-approved oxazolidinone antibiotic that may be better tolerated than linezolid; however, real-world clinical data are limited, particularly among patients receiving prolonged treatment courses. Our objective was to review our clinical experience with TED and des...

Descripción completa

Detalles Bibliográficos
Autores principales: Marini, Rachel V, Clarke, Lloyd, Shields, Ryan K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254022/
http://dx.doi.org/10.1093/ofid/ofy210.2074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254022/
http://dx.doi.org/10.1093/ofid/ofy210.2074

Ejemplares similares